EGFR and non-small cell lung carcinoma: In cultured NSCLC cells or xenograft tumor, the expression of HDGF is positively correlated with the activation of these pathways and the resistance to EGFR TKI; knocking down HDGF diminishes the activation of these pathways and sensitizes the cells to TKI inhibition (49).